6505--Rituximab Effective 09/15/2025 - 09/14/2026
Award Notice Posted
- Solicitation number
- 36E79725R0021
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Pfizer Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79725D0032 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center has awarded a contract (36E79725D0032) to Pfizer Inc. for Rituximab, a pharmaceutical product, with a total contract value of $74,038,216.80. The contract is effective from September 15, 2025, to September 14, 2026, and was awarded on April 29, 2025, following solicitation number 36E79725R0021. The contract was not set aside for any specific category of business, and Pfizer Inc., located in New York, NY, will provide the pharmaceutical product to the VA during the specified contract period.
Notice text
Awarded contract 36E79725D0032 to PFIZER INC for 74038216.80 on 2025-04-29.
Files
| File | Type | Posted |
|---|---|---|
| 36E79725D0032_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--Rituximab and Biosimilars | Solicitation | |
| 6505--Rituximab and Biosimilars | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity